Ginkgo Biloba Benefits: Evidence-Backed Effects
Ginkgo biloba is one of the oldest botanical supplements in continuous use. Extracted from the leaves of Ginkgo biloba trees, it contains two classes of active compounds — flavonoid glycosides and terpene lactones (ginkgolides and bilobalide) — that underpin its proposed biological effects. Understanding ginkgo biloba benefits means separating what research robustly supports from areas where the evidence is still accumulating.
Primary Evidenced Benefits
Cognitive Function in Older Adults
The most consistently studied benefit of ginkgo biloba is its effect on cognitive performance, particularly in older populations experiencing age-related cognitive decline. A large randomised, placebo-controlled trial — the GuidAge study — found that standardised ginkgo extract (EGb 761) did not significantly reduce the rate of progression to Alzheimer's disease over five years in community-dwelling elderly adults (Vellas et al., 2012). However, secondary analyses of trials using the same extract have shown improvements in attention, memory, and activities of daily living in patients with mild-to-moderate dementia (Kasper & Schubert, 2009).
The key takeaway: ginkgo may support cognitive function in those already experiencing decline, but evidence for prevention in healthy adults is weaker.
Peripheral Circulation
Ginkgo biloba flavonoids inhibit platelet-activating factor (PAF) and may support peripheral blood flow. Clinical trials have shown that standardised ginkgo extract can reduce symptoms of peripheral arterial disease such as intermittent claudication (walking distance before pain onset) (Pittler & Ernst, 2000). This circulatory benefit is among the better-supported effects of the herb.
Antioxidant Activity
Ginkgo flavonoids scavenge reactive oxygen species in vitro and in vivo. This antioxidant capacity is biologically plausible and documented in cell and animal studies, though large human intervention trials specifically measuring antioxidant biomarkers are fewer in number.
Secondary and Emerging Effects
- Tinnitus: Some trials have reported reductions in tinnitus severity with ginkgo, though results are inconsistent across studies and patient populations. It is not a first-line treatment.
- Anxiety: A small double-blind RCT by Woelk et al. (2007) found that EGb 761 reduced anxiety scores in patients with generalised anxiety disorder, though sample sizes were limited.
- Eye health: Ginkgo may support retinal blood flow and has been studied in the context of glaucoma and age-related macular conditions, but the clinical evidence is not yet sufficient to recommend it specifically for these conditions.
Where Evidence Is Weak
- Prevention of Alzheimer's disease in healthy adults: The GuidAge and GEMS trials both found no significant preventive effect (Vellas et al., 2012).
- Athletic performance enhancement: There is minimal high-quality evidence that ginkgo improves physical performance in healthy athletes.
- Sexual dysfunction: Some reports exist, but rigorous RCT evidence is lacking.
Who Gains Most
Based on the body of evidence, the people most likely to see meaningful benefit from ginkgo biloba are:
- Older adults with mild cognitive impairment or early-stage dementia
- Individuals with peripheral arterial disease or circulation concerns
- Those looking for a plant-based antioxidant addition to a broader supplement stack
Healthy younger adults looking for nootropic effects may find the evidence thinner than marketing suggests.
Realistic Expectations
Ginkgo biloba is not a dramatic cognitive enhancer or memory restorer for healthy individuals. It is a well-studied herbal extract with plausible mechanisms and documented benefits in specific populations. Most trials use standardised extracts — typically 240 mg/day of EGb 761 — over 12–24 weeks before effects are measured.
Products available at maxfit.ee such as MST Ginkgo Biloba 60caps, OstroVit Ginkgo Biloba Extract 50g, and 
BIOTECHUSA Ginkgo Biloba€18.90 In stock 90tabs each list their standardisation level on the label. Check that the extract is standardised to flavonoid glycosides and terpene lactones to align with studied forms.
Ginkgo biloba is generally well tolerated. It may interact with anticoagulant medications — anyone taking blood thinners should consult a physician before use.
FAQ
Does ginkgo biloba improve memory in healthy young people?
The evidence is limited. Trials in healthy young adults show inconsistent or small effects. Most robust evidence is in older adults with cognitive decline. Expectations of dramatic memory improvement in healthy young users are not supported by current RCT data.
How long does it take for ginkgo biloba to work?
Most clinical trials run for 12 to 24 weeks. Benefits, where they occur, tend to be gradual. Expecting results in one or two weeks is unlikely to be realistic based on current evidence.
Can I take ginkgo biloba every day?
Daily use over weeks to months is consistent with how it is used in published trials. There is no well-documented need for cycling. If you take anticoagulants or antiplatelet drugs, consult your doctor before starting.
References
Vellas, B., Coley, N., Ousset, P. J., Berrut, G., Dartigues, J. F., Dubois, B., Grandjean, H., Pasquier, F., Piette, F., Robert, P., Touchon, J., Garnier, P., Mathiex-Fortunet, H., & Andrieu, S. (2012). Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurology, 11(10), 851-859. https://pubmed.ncbi.nlm.nih.gov/22959217/
Pittler, M. H., & Ernst, E. (2000). Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. American Journal of Medicine, 108(4), 276-281. https://pubmed.ncbi.nlm.nih.gov/11014719/
Woelk, H., Arnoldt, K. H., Falk, G., & Kieser, M. (2007). Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial. Journal of Psychiatric Research, 41(6), 472-480. https://pubmed.ncbi.nlm.nih.gov/16808927/
